Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

FDMTFDMT
Showing 8 of 22 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in 4D MOLECULAR THERAPEUTICS IN

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 339,275 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $4.5M as of 2026-Q2. The position was increased (+3.3% shares). FDMT represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$4.5M

Current Shares

339,275

Total Value Change

+$855,151

Total Shares Change

+958

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
339,275
+3.3%
$4.5M0.0%$13.30
28
2026-Q1
Decreased
328,379
-7.1%
$3.1M0.0%$8.46
0
2025-Q4
Increased
353,391
+15.5%
$2.7M0.0%$7.58
30
2025-Q3
Increased
305,857
+3.7%
$2.7M0.0%$8.35
27
2025-Q2
Increased
295,041
+4.3%
$1.1M0.0%$3.84
26
2025-Q1
Decreased
282,781
-8.4%
$913,3830.0%$3.63
0
2024-Q4
Decreased
308,609
-8.8%
$1.7M0.0%$5.30
0
2024-Q3
Increased
338,317
+0.1%
$3.7M0.0%$10.83
27

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used